Oral lichen planus in Omeprazole - how severe and when it was recovered? (a real world drug study)

Summary:

We study how severe was Oral lichen planus, when it was recovered, drug effectiveness, race, and more among people who take Omeprazole (omeprazole). This phase IV clinical study is created by eHealthMe based on reports submitted to eHealthMe, and is updated regularly.

What is Omeprazole?

Omeprazole has active ingredients of omeprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 410,631 Omeprazole users. Check the latest studies of Omeprazole.

What is Oral lichen planus?

Oral lichen planus (a chronic inflammatory disease that causes bilateral white striations, papules, or plaques on the buccal mucosa) is found to be associated with 66 drugs and 220 conditions by eHealthMe. Check the latest studies of Oral lichen planus.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 22, 2026

12 people who have Oral lichen planus while taking Omeprazole were studied.

Could Omeprazole cause Oral lichen planus?

Severity of Oral lichen planus *:

least: 9.09 %
moderate: 63.64 %
severe: 27.27 %
most severe: 0.0 %

When people recovered from Oral lichen planus *:

while on drug: 0.0 %
after off the drug: 0.0 %
not yet: 100 %

Effectiveness of Omeprazole *:

not at all: 0.0 %
somewhat: 25.0 %
moderate: 12.5 %
high: 25.0 %
very high: 37.5 %

Race of the people *:

African American, Non-Hispanic: 0.0 %
American Indian/Alaska Native: 0.0 %
Asian: 12.5 %
Hispanic: 0.0 %
Native Hawaiians/Pacific Islanders: 0.0 %
Two or more races: 12.5 %
White, Non-Hispanic: 75.0 %

Time on Omeprazole *:

Gender of people when taking Omeprazole *:

female: 75 %
male: 25 %

Age of people when taking Omeprazole *:

Conditions people have *:

High Blood Pressure: 5 people, 41.67%
High Blood Cholesterol: 4 people, 33.33%
Stress And Anxiety: 2 people, 16.67%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 16.67%
Diabetes: 2 people, 16.67%
Allergies: 1 person, 8.33%
Anemia (less than the normal quantity of haemoglobin in the blood): 1 person, 8.33%
Chronic Thyroiditis (long lasting inflammation of thyroid gland): 1 person, 8.33%
Depression: 1 person, 8.33%
Fatty Liver: 1 person, 8.33%

Other drugs people take besides Omeprazole *:

Other side effects people have besides Oral lichen planus *:

Vision Problems: 1 person, 8.33%
Sore Throat (pain or irritation of the throat): 1 person, 8.33%
Pustular Psoriasis (raised bumps on the skin that are filled with pus): 1 person, 8.33%
Psoriatic Arthritis (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 8.33%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 8.33%
Polycystic Ovary Disease (cysts in the ovaries that occurs when the follicle stops developing): 1 person, 8.33%
Mouth Ulcers: 1 person, 8.33%
Lichen Planopilaris: 1 person, 8.33%
Joint Pain: 1 person, 8.33%
Inflammation: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Omeprazole and have Oral lichen planus?

Check whether Oral lichen planus is associated with a drug or a condition

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Oral lichen planus in Omeprazole

How the study uses the data?

The study is based on omeprazole (the active ingredients of Omeprazole). Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.